Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-06-13

FDA Approved: DOXAZOSIN — Supplemental Application (Upsher-Smith laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Upsher-Smith Laboratories, LLC. The action updates the product labeling under th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN MESYLATE)